Radiology Business
IV Contrast Shortage – 9 Ways to Conserve
Due to supply chain issues, the nationwide shortage of intravenous iodinated contrast media utilized in CT scans may last for 6-to-8 weeks. GE Healthcare has reported that all formulations and concentrations of Omnipaque (iohexol) will experience limited availability. The contrast material is manufactured in Shanghai, China, where a lockdown occurred due to COVID…
Read MoreRadiologists Among the Top 10 Most-Recruited Physicians in 2022
Radiologists are now among the top 10 most-recruited specialists. A report by Physicians Thrive revealed that recruiting is up among specialists, including radiologists, for the first time in many years. During the last 13 years, primary care physicians were the most highly-recruited physicians in the United States. However, when the COVID-19 pandemic created a significant…
Read MoreMedPAC Recommends No Medicare Payment Update for 2023
The Medicare Payment Advisory Commission (MedPAC) issued its latest report to Congress on March 15. Their opinion was simple and direct — Medicare payments don’t need to be increased in 2023. Their report stated, “Overall, access to clinician services for Medicare beneficiaries appears stable and comparable to that for privately insured individuals.” And they continued…
Read MoreTexas Physicians Win In No Surprises Act Law Suit
A U.S. district court judge granted the Texas Medical Association’s motion for summary judgment agreeing that the Department of Health and Human Services (HHS) ’s interpretation of the No Surprises Act did not line up with the law, as written, and as Congress intended. The ruling came on February 23, 2022. Judge Jeremy Kernodle concurred…
Read MoreCOVID-Delayed Screenings Increase Late-Stage Breast Cancer Diagnoses
The National Cancer Institute, in June 2020, expressed fears that declines in cancer screenings and delays in treatment due to the COVID-19 pandemic could contribute to an increase in rates of advanced cancer diagnoses and deaths through 2030. A recent study was led by Jade Zifei Zhou, MD, Ph.D., a hematology/oncology fellow at Moores Cancer…
Read More